PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2021-12-02 (98)

Date Title Company
02-Dec-2021 Takeda’s LIVTENCITY™ (maribavir) Now Available for Certain Individuals Ages 12 Years and Older With Post-Transplant Cytomegalovirus (CMV) Infection/Disease in the United States Businesswire